Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Essential Oils for BZRA Reduction in Psychiatric Outpatients
NCT05583240Phase 4Unknown
- Sponsor
- EPS Barthélemy Durand
- Start
- Apr 2021
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by EPS Barthélemy Durand. Primary endpoint: Number of medications prescribed at 4 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT05583240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05583240.